Navigation Links
Lexicon to Provide First Quarter 2012 Financial Results
Date:4/25/2012

nd intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
2. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
3. Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
4. Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Lexicon Announces Commencement of Rights Offering to Stockholders
6. Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
8. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
9. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
10. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
11. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 Reportbuyer.com has added a new market ... https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html This report analyzes ... by the following Product Segments: Implantable/Internal Cardiac Defibrillators, and ... the US, Canada , ... Asia-Pacific , Middle East ...
(Date:8/20/2014)... , Aug. 20, 2014 Children aren,t ... receive vaccinations to help prevent disease. The Centers ... for all adults, but currently, many adults are ... is National Immunization Awareness Month, and the American ... adults, especially those with lung disease, to talk ...
(Date:8/20/2014)... , August 20, 2014 ... market report titled "Monochloroacetic Acid (MCA) Market for Cellulosics, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... valued at USD 817.1 million in 2013 and is ... at a CAGR of 3.6% during the forecast period ...
Breaking Medicine Technology:Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 2American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4
... primary endpoint not met; plausibly,confounded by survival ... YORK, April 16, 2007 /PRNewswire-FirstCall/ -- ImClone,Systems ... results from the EPIC study - a ... ERBITUX(R),(Cetuximab) plus irinotecan to irinotecan alone in ...
... ProNAi Therapeutics,Inc., a biopharmaceutical company pioneering a ... interference (DNAi), today,announced that its lead oncology ... vivo efficacy in,xenograft mice for a number ... difficult-to-treat Burkitt's Lymphoma., Dr. Richard D. Gill, ...
Cached Medicine Technology:Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma 2
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... may help doctors diagnose and treat the most aggressive melanomas, ... that the deadliest skin cancers occur most often on the ... of sun exposure. These lesions also grow quickly and ... -- called "high mitotic rate" -- is associated with ...
(Date:8/20/2014)... to treating kidney failure by removing waste products from ... who suddenly developed the condition, in an analysis led ... Medicine. , Their findings, published online in the journal ... method that is standardly used for people with sudden ... the patient. , "Our findings question the accepted notion ...
(Date:8/20/2014)... (August 20, 2014) Research from Columbia University Medical ... in stomach cancer growth and that blocking nerve signals ... treatment for the disease. The study was conducted by ... with Duan Chen, MD, PhD, in Norway and is ... . , "Scientists have long observed that human and ...
(Date:8/20/2014)... 2014 The non-small cell lung cancer ... the offing across the top 8 developed nations, from ... around USD 8 billion by 2020-end, posting a CAGR ... projected to be driven by innovative therapies entering the ... efficient treatment, unlike the non-squamous segment. Thus, patients with ...
(Date:8/20/2014)... Santa Rosa, CA (PRWEB) August 20, 2014 ... is the 12 per diode panel band perfect spectrum that ... plants are most likely to use during photosynthesis. A ... spectral bands is that they almost exclusively reside between 440-480 ... 620-680 on the red side of the spectrum. The KIND ...
Breaking Medicine News(10 mins):Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4Health News:Cheap LED Grow Lights Are Quickly Being Replaced by Premium Grow Lights 2
... UCNN ), the market leader in on-demand contact center ... a leading,healthcare provider of Medicare plans with more than 200,000 ... This new customer came to UCN to create a more ... of the company,s,contact center locations. They chose the inContact platform ...
... Stayhealthy, Inc. and EF,Recovery announced today that they ... Fire Rescue Wellness Corporation to bring,revolutionary health and fitness ... "The health and safety of our ... Fire Chief of South Kitsap Fire Rescue. "As our ...
... 19 This month the hit television,show ,Living in ... ,Living in Style, is a half-hour news magazine television,series ... its clinically,proven ability to reduce body fat and increase ... the premier brand of health supplements to,the consumer and ...
... Nov. 19 People in the middle of,separation ... dread.,Long-standing family traditions are shattered; the hope and ... loneliness and depression. This year,s,economic downturn will add ... or,divorced and facing already-difficult financial circumstances. , ...
... With issues around patient comfort gaining,momentum, hospitals and healthcare ... and welfare. This is leading to a growing demand ... a greater,number of patients and not just the aged ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...
... Historic nonprofit offers help to SF neighborhood with highest citywide ... SAN FRANCISCO, Nov. 19 On World Diabetes ... blood sugar check ups, as well as diabetic foot and ... free massages to San Francisco,s poor and homeless. St. Anthony,s ...
Cached Medicine News:Health News:Leading Healthcare Provider Signs Agreement With UCN for inContact 2Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 2Health News:Washington Fire Firefighters Launch First of Its Kind Pilot Program on Health and Fitness 3Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 2Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 3Health News:Holiday Season Amplifies Hurt of Separation and Divorce: Economic Woes Add to Pressure 2Health News:Patient Temperature Management Systems Enjoying Wider Usage 2Health News:Patient Temperature Management Systems Enjoying Wider Usage 3Health News:Turkey Tips, Massage, and a Blood Test: St. Anthony's Celebrates Diabetes Day in New Green Clinic 2
Ahmed Glaucoma Valve (small size)....
... established. Provides a robust and durable drainage ... on the globe. Pressure Ridge Molteno Implants ... by Tenons tissue, acts as a Pressure ... range of implants allows the surgeon to ...
... a robust and durable drainage system. Preplaced ... globe. Pressure Ridge Molteno Implants have a ... tissue, acts as a Pressure sensitive biological ... implants allows the surgeon to choose the ...
... Baerveldt Glaucoma Implants feature a low ... and reduced complications. The single-quadrant insertion is ... area seton plate to be installed with ... patented fenestrations of the Baerveldt implant were ...
Medicine Products: